CT-EV exerted potent immunomodulatory effects in the RA mouse model by reducing pro-inflammatory cytokines in immune cells, altering immune cell populations, increasing serum IL-4 levels, and attenuating cartilage damage. This evidence concerns the gene IL4 and rheumatoid arthritis.